Last reviewed · How we verify

Vivjoa — Competitive Intelligence Brief

Vivjoa (OTESECONAZOLE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Azole Antifungal [EPC]. Area: Infectious Disease.

marketed Azole Antifungal [EPC] Cytochrome P450 3A4 Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Vivjoa (OTESECONAZOLE) — Mycovia Pharms. Vivjoa works by inhibiting the enzyme Cytochrome P450 3A4, which is involved in the synthesis of ergosterol, a critical component of fungal cell membranes.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Vivjoa TARGET OTESECONAZOLE Mycovia Pharms marketed Azole Antifungal [EPC] Cytochrome P450 3A4 2022-01-01
Agenerase AMPRENAVIR GSK marketed Protease Inhibitor Cytochrome P450 3A4 1999-01-01
Viracept NELFINAVIR Agouron Pharms marketed Protease Inhibitor Cytochrome P450 3A4 1997-01-01
Diflucan Fluconazole Pfizer marketed Azole Antifungal [EPC] Cytochrome P450 3A4 1990-01-01
Versed midazolam Generic (originally Roche) marketed Benzodiazepine (short-acting) Multidrug resistance protein 1, Cytochrome P450 3A4, GABA A receptor alpha-3/beta-2/gamma-2 1985-12-20
Xanax alprazolam Generic (originally Upjohn/Pfizer) marketed Benzodiazepine (triazolobenzodiazepine) Bromodomain-containing protein 4, Platelet-activating factor receptor, Cytochrome P450 3A4 1981-10-16
Pyrazinamide PYRAZINAMIDE Dava Pharms Inc marketed Antimycobacterial [EPC] Cytochrome P450 3A4 1971-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (Azole Antifungal [EPC] class)

  1. · 4 drugs in this class
  2. Bausch Health · 2 drugs in this class
  3. Bayer AG · 1 drug in this class
  4. Johnson & Johnson (Janssen) · 1 drug in this class
  5. Mycovia Pharms · 1 drug in this class
  6. Pfizer · 1 drug in this class
  7. Pfizer Inc. · 1 drug in this class
  8. Sebela Ireland Ltd · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Vivjoa — Competitive Intelligence Brief. https://druglandscape.com/ci/oteseconazole. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: